Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 1 year 18 weeks ago

5 DMD Data Readouts to Watch in 2024

Wed, 06/05/2024 - 02:00
5 DMD Data Readouts to Watch in 2024 5/6/2024

AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases

Wed, 06/05/2024 - 02:00
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024

FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment

Tue, 06/04/2024 - 02:00
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024

ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout

Fri, 05/31/2024 - 02:00
ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout 5/31/2024

Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial

Fri, 05/31/2024 - 02:00
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial 5/31/2024

FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval

Fri, 05/31/2024 - 02:00
FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval 5/31/2024

ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts

Fri, 05/31/2024 - 02:00
ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts 5/31/2024

Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024

Fri, 05/31/2024 - 02:00
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024 5/31/2024

BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM

Thu, 05/30/2024 - 02:00
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM 5/30/2024

Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room

Thu, 05/30/2024 - 02:00
Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room 5/30/2024

Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication

Thu, 05/30/2024 - 02:00
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication 5/30/2024

Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors

Thu, 05/30/2024 - 02:00
Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors 5/30/2024

BioSpace x DIA: Advanced Therapy Product Regulatory Confusion

Thu, 05/30/2024 - 02:00
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion 5/30/2024

BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa

Thu, 05/30/2024 - 02:00
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa 5/30/2024

Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises

Thu, 05/30/2024 - 02:00
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises 5/30/2024

Moving Up: 5 Tips for Transitioning From Co-Worker to Manager

Thu, 05/30/2024 - 02:00
Moving Up: 5 Tips for Transitioning From Co-Worker to Manager 5/30/2024

Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology

Wed, 05/29/2024 - 02:00
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology 5/29/2024

Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris

Wed, 05/29/2024 - 02:00
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris 5/29/2024

Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters

Wed, 05/29/2024 - 02:00
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters 5/29/2024

Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study

Wed, 05/29/2024 - 02:00
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study 5/29/2024